高特异的双酶介导的有效载荷释放来自涂的颗粒
Paul D Thornton1, Andreas Heise
1School of Chemical Sciences, Dublin City University, Dublin 9, Ireland.
Journal of the American Chemical Society
|January 27, 2010
概括
研究人员开发了酶触发的二氧化颗粒,用于控制分子的释放. 这种对刺激有反应的系统通过在需要时降解生物活性外来准确地释放客人.
科学领域:
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
- 纳米技术 纳米技术
背景情况:
- 对于受控释放的应用来说,响应刺激的材料至关重要.
- 孔状载体提供高有效载荷能力,但需要有效的门机制.
- 酶介导释放为有效载荷传递提供了一种特定且可调节的方法.
研究的目的:
- 开发一种酶响应的门机制,用于从多孔的二氧化颗粒中释放客分子.
- 使用Fmoc化学在纳米颗粒上合成和表征外.
- 为了证明由酶化水解触发的宏分子客体的受控释放.
主要方法:
- 通过Fmoc化学在无机二氧化颗粒上合成外.
- 在功能化颗粒中捕获宏分子客分子.
- 外的酶性水解触发了客分子的释放.
- 粒子结构和释放动态的表征.
主要成果:
- 成功合成了涂上精确控制的生物活性外的二氧化颗粒.
- 证明了外的酶介导降解.
- 在酶性水解过程中实现了被困的宏分子客分子的选择性释放.
- 证实了开发的门机制的刺激反应性.
结论:
- 外的酶介导水解提供了一个有效的按需释放机制.
- Fmoc化学可以精确合成生物活性外,以控制有效载荷的传递.
- 这种刺激反应系统对先进的药物输送和其他需要控制分子释放的应用有前途.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


